1

In Vivo Preclinical Assessment of the VEGF Targeting Potential of the Newly Synthesized [52Mn]Mn-DOTAGA-Bevacizumab Using Experimental Cervix Carcinoma Mouse Model

eeizyj6avdfg
Among humanized monoclonal antibodies. bevacizumab specifically binds to vascular endothelial growth factor A (VEGF-A). VEGF-A is an overexpressed biomarker in cervix carcinoma and is involved in the development and maintenance of tumor-associated neo-angiogenesis. The non-invasive positron emission tomography using radiolabeled target-specific antibodies (immuno-PET) provides the lon... https://www.roneverhart.com/Mike-and-Ike-Original-Fruits-Candy-Mini-Packs-24-Piece-Box/
Report this page

Comments

    HTML is allowed

Who Upvoted this Story